Advances in Molecular Target and Anti-Cancer Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 49
Special Issue Editor
Special Issue Information
Dear Colleagues,
The identification of new biomarkers and molecular targets, as well as the development of safe and effective anticancer treatments, continues to be a priority in the healthcare field, especially in the context of the global increase in cancer cases. Currently, therapies include small molecules, enzymatic inhibitors, natural products, agents targeting DNA, and metal complexes. These research efforts open up prospects for creating new compounds with enhanced activity, superior bioavailability, and the ability to overcome treatment resistance, thereby contributing to the development of more personalized and effective therapies for oncology patients. This Special Issue, "Advances in Molecular Target and Anti-Cancer Therapies", aims to investigate current research on the identification of new biomarkers and molecular targets, as well as the design and development of safer and more precise anti-tumor drugs capable of overcoming existing limitations and addressing the urgent needs of oncology patients. It also examines emerging technologies such as nanomedicine and genetic editing, which promise more personalized and efficient therapies. Original research articles, review articles, and short communications within (but not restricted to) the described research fields are welcome.
Dr. Laura Denisa Dragu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- conventional therapy
- targeted therapy
- immunotherapy
- natural compounds
- combinatorial therapy
- molecular target
- molecular mechanism
- drug design
- drug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
